Allurion executes 3(a)(9) exchange with stockholders

Allurion Technologies exchanged an aggregate of 392,766 shares of common stock for pre-funded common stock warrants on July 21, 2026. The transaction is exempt from registration under Section 3(a)(9) of the Securities Act.